Haymarket, VA, United States of America

Catherine R Auge

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: American Type Culture Collection. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catherine R Auge. Retrieved from https://idiyas.com/inventor/catherine-r-auge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Catherine R Auge: Innovator in Diabetes Treatment

Introduction

Catherine R Auge is a notable inventor based in Haymarket, Virginia, who has made significant contributions to the field of diabetes treatment. With a focus on identifying biological markers associated with type 2 diabetes, her work aims to enhance diagnosis and prognosis for this prevalent condition.

Latest Patents

Catherine holds a patent for "Methods for treatment of type 2 diabetes." This invention relates to the identification of biological markers that indicate an increased risk of developing diabetes. The methods she developed may lead to new therapeutic targets and innovative treatments for the prevention and management of diabetes.

Career Highlights

Catherine is affiliated with the American Type Culture Collection, where she applies her expertise in biological research. Her work is pivotal in advancing the understanding of diabetes and improving patient outcomes through innovative solutions.

Collaborations

Catherine has collaborated with esteemed colleagues, including Cohava Gelber and Liping Liu, to further her research and enhance the impact of her inventions.

Conclusion

Catherine R Auge's contributions to diabetes treatment through her innovative patent exemplify her commitment to improving healthcare. Her work continues to pave the way for advancements in the diagnosis and treatment of this critical health issue.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…